Key result
Resveratrol and energy restriction increase circulating SIRT1 and lower sympathetic activity in healthy adults.
Why the study?
SIRT1 has been linked to longevity and protection against cardiometabolic diseases, but little is known about how it influences human vascular function.
Does resveratrol supplementation compared to energy restriction improve vascular reactivity and SIRT1 activation in healthy adults?
RCT (n=48)
Does resveratrol supplementation compared to energy restriction improve vascular reactivity and SIRT1 activation in healthy adults?
p-value: p=<0.001
Both energy restriction and resveratrol supplementation for 30 days increased circulating SIRT1 and reduced sympathetic activity in healthy adults.
Resveratrol may mimic energy restriction for SIRT1 activation and sympathetic reduction in healthy adults; extends RCT evidence but leaves clinical outcomes open.
Background: Sirtuin 1 (SIRT1) has been associated with longevity and protection against cardiometabolic diseases, but little is known about how it influences human vascular function. Therefore, this study evaluated the effects of SIRT1 activation by resveratrol and energy restriction on vascular reactivity in adults. Methods: A randomized trial allocated 48 healthy adults (24 women and 24 men), aged 55 to 65 years, to resveratrol supplementation or energy restriction for 30 days. Blood lipids, glucose, insulin, C-reactive protein, noradrenaline, SIRT1 (circulating and gene expression), and flow-mediated vasodilation (FMD) and nitrate-mediated vasodilation (NMD) were measured. Results: Both interventions increased circulating SIRT1 (p < 0.001). Pre- and post-tests changes of plasma noradrenaline were significant for both groups (resveratrol: p = 0.037; energy restriction: p = 0.008). Baseline circulating SIRT1 was inversely correlated with noradrenaline (r = −0.508; p < 0.01), and post-treatment circulating SIRT1 was correlated with NMD (r = 0.433; p < 0.01). Circulating SIRT1 was a predictor of FMD in men (p = 0.045), but not in women. SIRT1 was an independent predictor of NMD (p = 0.026) only in the energy restriction group. Conclusions: Energy restriction and resveratrol increased circulating SIRT1 and reduced sympathetic activity similarly in healthy adults. SIRT1 was independently associated with NMD only in the energy restriction group.
No takes yet. Share an insight, caveat, or question.
Gonçalinho et al. (2023) conducted an RCT in Healthy adults (n=48). Resveratrol supplementation vs. Energy restriction was evaluated on Circulating SIRT1 (p=<0.001). Resveratrol supplementation and energy restriction both significantly increased circulating SIRT1 (p < 0.001) and reduced sympathetic activity in healthy adults over 30 days.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: